Loading...
Pharmacogenetics of Efavirenz Discontinuation for Reported Central Nervous System Symptoms Appears to Differ by Race
BACKGROUND: Efavirenz frequently causes central nervous system (CNS) symptoms. We evaluated genetic associations with efavirenz discontinuation for CNS symptoms within 12 months of treatment initiation. METHODS: Patients had initiated efavirenz-containing regimens at an HIV primary care clinic in th...
Na minha lista:
| Udgivet i: | Pharmacogenet Genomics |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014672/ https://ncbi.nlm.nih.gov/pubmed/27509478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000238 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|